187 related articles for article (PubMed ID: 18166944)
1. [Favorable outcome of gemcitabine-induced acute respiratory distress syndrome].
Bonnichon A; Vedrine L; Aletti M; Le Moulec S; Borne M; Margery J; Bauduceau O; Fayolle M; Ceccaldi B
Rev Pneumol Clin; 2007 Dec; 63(6):379-83. PubMed ID: 18166944
[TBL] [Abstract][Full Text] [Related]
2. [Severe interstitial pneumonitis related to Gemcitabine].
Sabria-Trias J; Bonnaud F; Sioniac M
Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine-induced respiratory failure associated with elevated erythrocyte sedimentation rate (ESR).
Davidoff S; Shah RD; Arunabh T
Respir Med; 2006 Apr; 100(4):760-3. PubMed ID: 16199150
[TBL] [Abstract][Full Text] [Related]
4. Favorable outcome of gemcitabine-induced respiratory distress syndrome.
Girard T; Mouthon L; Boaziz C; Andre MH; Guillevin L
Ann Med Interne (Paris); 2000 Jun; 151(4):306-8. PubMed ID: 10922960
[TBL] [Abstract][Full Text] [Related]
5. An autopsy case of acute pulmonary toxicity associated with gemcitabine.
Maniwa K; Tanaka E; Inoue T; Kato T; Sakuramoto M; Minakuchi M; Maeda Y; Noma S; Kobashi Y; Taguchi Y
Intern Med; 2003 Oct; 42(10):1022-5. PubMed ID: 14606719
[TBL] [Abstract][Full Text] [Related]
6. Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine.
Ciotti R; Belotti G; Facchi E; Cantù A; D'Amico A; Gatti C
Ann Oncol; 1999 Aug; 10(8):997. PubMed ID: 10509166
[No Abstract] [Full Text] [Related]
7. [Acute respiratory distress syndrome after antineoplastic chemotherapy. Probable role of gemcitabine].
de Lavigerie B; Joasson JM
Presse Med; 2001 May 5-12; 30(17):851-4. PubMed ID: 11402938
[TBL] [Abstract][Full Text] [Related]
8. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
Pavlakis N; Bell DR; Millward MJ; Levi JA
Cancer; 1997 Jul; 80(2):286-91. PubMed ID: 9217042
[TBL] [Abstract][Full Text] [Related]
9. [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].
Mommens V; Bosquée L; D'Orio V
Rev Med Liege; 2003 Mar; 58(3):123-6. PubMed ID: 12723505
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer.
Shaib W; Lansigan F; Cornfeld D; Syrigos K; Saif MW
JOP; 2008 Nov; 9(6):708-14. PubMed ID: 18981552
[TBL] [Abstract][Full Text] [Related]
11. Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option.
Gontero P; Marini L; Frea B
BJU Int; 2005 Nov; 96(7):970-6. PubMed ID: 16225511
[No Abstract] [Full Text] [Related]
12. Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatment.
Badger J; Kang S; Uzieblo A; Srinivas S
J Clin Oncol; 2005 Oct; 23(28):7224-5. PubMed ID: 16192608
[No Abstract] [Full Text] [Related]
13. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary gemcitabine delivery for treating lung cancer: pharmacokinetics and acute lung injury aspects in animals.
Min R; Li T; Du J; Zhang Y; Guo J; Lu WL
Can J Physiol Pharmacol; 2008 May; 86(5):288-98. PubMed ID: 18432290
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine-induced pulmonary toxicity.
Chi DC; Brogan F; Turenne I; Zelonis S; Schwartz L; Saif MW
Anticancer Res; 2012 Sep; 32(9):4147-9. PubMed ID: 22993376
[TBL] [Abstract][Full Text] [Related]
16. BOOP as a rare complication of gemcitabine therapy.
Kawsar HI; Spiro TP; Cocco A; Daw HA
BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689600
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine in bladder cancer.
El Karak F; Flechon A
Expert Opin Pharmacother; 2007 Dec; 8(18):3251-6. PubMed ID: 18035967
[TBL] [Abstract][Full Text] [Related]
18. [A case of interstitial pneumonia during gemcitabine and cisplatin chemotherapy for locally advanced bladder cancer].
Matsumura E; Ashikari A; Tasaki S; Haranaga S; Toyosato T; Ashimine S; Machida N; Oshiro Y; Saito S
Hinyokika Kiyo; 2011 Feb; 57(2):81-5. PubMed ID: 21412040
[TBL] [Abstract][Full Text] [Related]
19. Feasiblity study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function.
Carles J; Suárez C; Mesía C; Nogué M; Font A; Doménech M; Suárez M; Tusquets I; Gallén M; Albanell J; Fabregat X
Clin Transl Oncol; 2006 Oct; 8(10):755-7. PubMed ID: 17074675
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor support.
Briasoulis E; Froudarakis M; Milionis HJ; Peponis I; Constantopoulos S; Pavlidis N
Respiration; 2000; 67(6):680-3. PubMed ID: 11124653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
